Postoperative adjuvant radiotherapy following radical hysterectomy in the treatment of stage Ib II-proximal cervical cancer

F. Volterrani, L. Lozza, S. Tana, N. Di Muzio

Research output: Contribution to journalArticle

Abstract

In the years 1971/85, 327 patients with Stage Ib, II-proximal cervical carcinoma underwent radical hysterectomy and pelvic + lumbar-aortic lymphadenctomy. 40 patients (12.2%) who presented nodal metastases were candidates for post-operative adjuvant radiotherapy (RT), but this was not performed in 12 cases (30.0%) owing to various causes not connected with oncologic conditions. The overall N+ cases showed a 46.1% cumulative risk of pelvic relapse at 5-years and a 15.3% cumulative risk of distant metastases, against the 5.8% and 1.3% observed for the N-cases. In the group submitted to adjuvant RT the 5-year cumulative risk of recurrences was respectively 30.8% for pelvic relapse and 15.4% for distant metastases, while in the untreated group the pelvic relapse risk was 36.8% and the risk of distant metastases 21.1%. Relapse free survival (RFS) at 5-years totalled 48.8% for the N+ cases against 87.6% for the N-ones. 5-year RFS for the N+ case group was respectively 53.4% in the group submitted to adjuvant RT, against 46.7% observed for the untreated group. On the whole no statistically significant differences were observed as regards the administration of adjuvant RT. The Authors discuss the role and indications of postoperative adjuvant RT in the treatment of early stage cervical cancer, with regard to the various high risk factors.

Original languageEnglish
Pages (from-to)131-140
Number of pages10
JournalCervix and the Lower Female Genital Tract
Volume8
Issue number1
Publication statusPublished - 1990

Fingerprint

Adjuvant Radiotherapy
Hysterectomy
Uterine Cervical Neoplasms
Recurrence
Neoplasm Metastasis
Therapeutics
Survival
Carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

@article{de6594a4fa8e4ba99a567559094e33ad,
title = "Postoperative adjuvant radiotherapy following radical hysterectomy in the treatment of stage Ib II-proximal cervical cancer",
abstract = "In the years 1971/85, 327 patients with Stage Ib, II-proximal cervical carcinoma underwent radical hysterectomy and pelvic + lumbar-aortic lymphadenctomy. 40 patients (12.2{\%}) who presented nodal metastases were candidates for post-operative adjuvant radiotherapy (RT), but this was not performed in 12 cases (30.0{\%}) owing to various causes not connected with oncologic conditions. The overall N+ cases showed a 46.1{\%} cumulative risk of pelvic relapse at 5-years and a 15.3{\%} cumulative risk of distant metastases, against the 5.8{\%} and 1.3{\%} observed for the N-cases. In the group submitted to adjuvant RT the 5-year cumulative risk of recurrences was respectively 30.8{\%} for pelvic relapse and 15.4{\%} for distant metastases, while in the untreated group the pelvic relapse risk was 36.8{\%} and the risk of distant metastases 21.1{\%}. Relapse free survival (RFS) at 5-years totalled 48.8{\%} for the N+ cases against 87.6{\%} for the N-ones. 5-year RFS for the N+ case group was respectively 53.4{\%} in the group submitted to adjuvant RT, against 46.7{\%} observed for the untreated group. On the whole no statistically significant differences were observed as regards the administration of adjuvant RT. The Authors discuss the role and indications of postoperative adjuvant RT in the treatment of early stage cervical cancer, with regard to the various high risk factors.",
author = "F. Volterrani and L. Lozza and S. Tana and {Di Muzio}, N.",
year = "1990",
language = "English",
volume = "8",
pages = "131--140",
journal = "Cervix and the Lower Female Genital Tract",
issn = "0393-3512",
number = "1",

}

TY - JOUR

T1 - Postoperative adjuvant radiotherapy following radical hysterectomy in the treatment of stage Ib II-proximal cervical cancer

AU - Volterrani, F.

AU - Lozza, L.

AU - Tana, S.

AU - Di Muzio, N.

PY - 1990

Y1 - 1990

N2 - In the years 1971/85, 327 patients with Stage Ib, II-proximal cervical carcinoma underwent radical hysterectomy and pelvic + lumbar-aortic lymphadenctomy. 40 patients (12.2%) who presented nodal metastases were candidates for post-operative adjuvant radiotherapy (RT), but this was not performed in 12 cases (30.0%) owing to various causes not connected with oncologic conditions. The overall N+ cases showed a 46.1% cumulative risk of pelvic relapse at 5-years and a 15.3% cumulative risk of distant metastases, against the 5.8% and 1.3% observed for the N-cases. In the group submitted to adjuvant RT the 5-year cumulative risk of recurrences was respectively 30.8% for pelvic relapse and 15.4% for distant metastases, while in the untreated group the pelvic relapse risk was 36.8% and the risk of distant metastases 21.1%. Relapse free survival (RFS) at 5-years totalled 48.8% for the N+ cases against 87.6% for the N-ones. 5-year RFS for the N+ case group was respectively 53.4% in the group submitted to adjuvant RT, against 46.7% observed for the untreated group. On the whole no statistically significant differences were observed as regards the administration of adjuvant RT. The Authors discuss the role and indications of postoperative adjuvant RT in the treatment of early stage cervical cancer, with regard to the various high risk factors.

AB - In the years 1971/85, 327 patients with Stage Ib, II-proximal cervical carcinoma underwent radical hysterectomy and pelvic + lumbar-aortic lymphadenctomy. 40 patients (12.2%) who presented nodal metastases were candidates for post-operative adjuvant radiotherapy (RT), but this was not performed in 12 cases (30.0%) owing to various causes not connected with oncologic conditions. The overall N+ cases showed a 46.1% cumulative risk of pelvic relapse at 5-years and a 15.3% cumulative risk of distant metastases, against the 5.8% and 1.3% observed for the N-cases. In the group submitted to adjuvant RT the 5-year cumulative risk of recurrences was respectively 30.8% for pelvic relapse and 15.4% for distant metastases, while in the untreated group the pelvic relapse risk was 36.8% and the risk of distant metastases 21.1%. Relapse free survival (RFS) at 5-years totalled 48.8% for the N+ cases against 87.6% for the N-ones. 5-year RFS for the N+ case group was respectively 53.4% in the group submitted to adjuvant RT, against 46.7% observed for the untreated group. On the whole no statistically significant differences were observed as regards the administration of adjuvant RT. The Authors discuss the role and indications of postoperative adjuvant RT in the treatment of early stage cervical cancer, with regard to the various high risk factors.

UR - http://www.scopus.com/inward/record.url?scp=0025204232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025204232&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025204232

VL - 8

SP - 131

EP - 140

JO - Cervix and the Lower Female Genital Tract

JF - Cervix and the Lower Female Genital Tract

SN - 0393-3512

IS - 1

ER -